Certified by Founder
Lodge
MAYD: MEDS AT YOUR DOORSTEP
start up
Germany
- Berlin
- 27/01/2022
- Series A
- $34,000,000
MAYD delivers meds to your doorstep in 30 minutes, free of charge, 365 days a year. We are building Europe’s first telepharmacy platform, offering over 3,000 healthcare-related goods in a more convenient, more supportive, and more consultative way. Backed by world-class investors with over $45M shortly after launch, our team consists of serial entrepreneurs and experienced operators who are passionate about helping people get their meds faster when they need them most.
Interested in joining us on our mission to make people’s lives a little bit healthier and easier? See all our job openings here: https://boards.eu.greenhouse.io/mayd
- Industry Pharmaceutical Manufacturing
- Website https://www.getmayd.com/en-de/
- LinkedIn https://www.linkedin.com/company/mayd-meds-at-your-doorstep/about/
WealthAi | $1,000,000 | (Jan 30, 2026)
Checkbox | $23,000,000 | (Jan 30, 2026)
PaleBlueDot AI | $150,000,000 | (Jan 30, 2026)
Mesh Security | $12,000,000 | (Jan 30, 2026)
Datalinx AI | $4,200,000 | (Jan 30, 2026)
Ressio Software | Undisclosed Amount | (Jan 30, 2026)
Co-reactive | $7,754,157 | (Jan 30, 2026)
Arkero | $6,000,000 | (Jan 30, 2026)
Redwood Materials | $425,000,000 | (Jan 30, 2026)
Twogee Biotech | $2,575,886 | (Jan 30, 2026)
Levellr | $2,500,000 | (Jan 30, 2026)
Indigo(1) | $50,000,000 | (Jan 30, 2026)
heyData | $16,500,000 | (Jan 30, 2026)